Building a strong, risk-based technology compliance foundation to create competitive advantage
The pharmaceutical and life sciences industry is currently facing unprecedented compliance challenges, and the close regulatory scrutiny of the industry is unlikely to abate anytime soon. Globalisation, information protection requirements (privacy, security), business partnerships, heightened transparency expectations, external reporting obligations, and other drivers force companies to re-examine their enterprise approach to IT governance, risk, and compliance.
New and different risks and compliance requirements are emerging as companies increase their reliance on technology to achieve the necessary transformation of commercial and R&D processes, extend the walls of the virtual organisation, automate business processes, share increasing amounts of sensitive information and data on a global basis, and to ultimately create a competitive business advantage for the company.
PricewaterhouseCoopers (PwC) can help your company develop an integrated IT governance, risk and compliance (GRC) programme.
